Catalyst Biosciences (NASDAQ: CBIO)
Some price data may be temporarily unavailable.
Catalyst Biosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Catalyst Biosciences Company Info
Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.
News & Analysis
Featured Article
2 Biotech Stocks That Tanked This Week: Can They Recover?
A bad week for these two biotechs could be a good week for bargain shoppers.
Cory Renauer | Jun 22, 2018
Featured Article
Why Biogen, Baytex Energy, and Catalyst Biosciences Slumped Today
Find out why good news elsewhere hurt some of these stocks.
Dan Caplinger | Jun 18, 2018
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.